BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 26442456)

  • 1. A strategy to discover decoy chemokine ligands with an anti-inflammatory activity.
    Abboud D; Daubeuf F; Do QT; Utard V; Villa P; Haiech J; Bonnet D; Hibert M; Bernard P; Galzi JL; Frossard N
    Sci Rep; 2015 Oct; 5():14746. PubMed ID: 26442456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation.
    Perros F; Hoogsteden HC; Coyle AJ; Lambrecht BN; Hammad H
    Allergy; 2009 Jul; 64(7):995-1002. PubMed ID: 19630858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of Th2 chemokine receptors on T cells from atopic and nonatopic asthmatics in response to Der p 1-pulsed dendritic cells.
    Maneechotesuwan K; Wongkajornsilp A; Huabprasert S; Kasetsinsombat K; Suthumansami T
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S62-70. PubMed ID: 20364559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of 5,6-dihydroergosteol-glucoside on atopic dermatitis-like skin lesions via suppression of NF-κB and STAT activation.
    Jung M; Lee TH; Oh HJ; Kim H; Son Y; Lee EH; Kim J
    J Dermatol Sci; 2015 Sep; 79(3):252-61. PubMed ID: 26100037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of chemokine receptor CCR4 and its ligands (CCL17 and CCL22) in murine contact hypersensitivity.
    Kusumoto M; Xu B; Shi M; Matsuyama T; Aoyama K; Takeuchi T
    J Interferon Cytokine Res; 2007 Nov; 27(11):901-10. PubMed ID: 18052724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor.
    Bonecchi R; Locati M; Galliera E; Vulcano M; Sironi M; Fra AM; Gobbi M; Vecchi A; Sozzani S; Haribabu B; Van Damme J; Mantovani A
    J Immunol; 2004 Apr; 172(8):4972-6. PubMed ID: 15067078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination.
    Bayry J; Tchilian EZ; Davies MN; Forbes EK; Draper SJ; Kaveri SV; Hill AV; Kazatchkine MD; Beverley PC; Flower DR; Tough DF
    Proc Natl Acad Sci U S A; 2008 Jul; 105(29):10221-6. PubMed ID: 18621704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung.
    Santulli-Marotto S; Boakye K; Lacy E; Wu SJ; Luongo J; Kavalkovich K; Coelho A; Hogaboam CM; Ryan M
    PLoS One; 2013; 8(12):e81465. PubMed ID: 24339934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that phospholipase-C-dependent, calcium-independent mechanisms are required for directional migration of T-lymphocytes in response to the CCR4 ligands CCL17 and CCL22.
    Cronshaw DG; Kouroumalis A; Parry R; Webb A; Brown Z; Ward SG
    J Leukoc Biol; 2006 Jun; 79(6):1369-80. PubMed ID: 16614259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CCR4 antagonist ameliorates atopic dermatitis-like skin lesions induced by dibutyl phthalate and a hydrogel patch containing ovalbumin.
    Matsuo K; Hatanaka S; Kimura Y; Hara Y; Nishiwaki K; Quan YS; Kamiyama F; Oiso N; Kawada A; Kabashima K; Nakayama T
    Biomed Pharmacother; 2019 Jan; 109():1437-1444. PubMed ID: 30551395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct conformations of the chemokine receptor CCR4 with implications for its targeting in allergy.
    Viney JM; Andrew DP; Phillips RM; Meiser A; Patel P; Lennartz-Walker M; Cousins DJ; Barton NP; Hall DA; Pease JE
    J Immunol; 2014 Apr; 192(7):3419-27. PubMed ID: 24563252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surrogate antibodies that specifically bind and neutralize CCL17 but not CCL22.
    Santulli-Marotto S; Fisher J; Petley T; Boakye K; Panavas T; Luongo J; Kavalkovich K; Rycyzyn M; Wu B; Gutshall L; Coelho A; Hogaboam CM; Ryan M
    Monoclon Antib Immunodiagn Immunother; 2013 Jun; 32(3):162-71. PubMed ID: 23750473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous application of peptidoglycan from Staphylococcus aureus induces infiltration of CCR4+ cells into mouse skin.
    Matsui K; Nishikawa A
    J Investig Allergol Clin Immunol; 2011; 21(5):354-62. PubMed ID: 21905498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6.
    Williams TC; Jackson DJ; Maltby S; Walton RP; Ching YM; Glanville N; Singanayagam A; Brewins JJ; Clarke D; Hirsman AG; Loo SL; Wei L; Beale JE; Casolari P; Caramori G; Papi A; Belvisi M; Wark PAB; Johnston SL; Edwards MR; Bartlett NW
    Am J Respir Cell Mol Biol; 2021 Mar; 64(3):344-356. PubMed ID: 33264064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity.
    Scheu S; Ali S; Ruland C; Arolt V; Alferink J
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A degradatory fate for CCR4 suggests a primary role in Th2 inflammation.
    Anderson CA; Patel P; Viney JM; Phillips RM; Solari R; Pease JE
    J Leukoc Biol; 2020 Mar; 107(3):455-466. PubMed ID: 32052476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive effects of a novel CC chemokine receptor 4 antagonist on Th2 cell trafficking in ligand- and antigen-induced mouse models.
    Komiya T; Sugiyama T; Takeda K; Watanabe N; Imai M; Kokubo M; Tokuda N; Ochiai H; Habashita H; Shibayama S
    Eur J Pharmacol; 2013 Nov; 720(1-3):335-43. PubMed ID: 24140571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCL17 production by dendritic cells is required for NOD1-mediated exacerbation of allergic asthma.
    Ait Yahia S; Azzaoui I; Everaere L; Vorng H; Chenivesse C; Marquillies P; Duez C; Delacre M; Grandjean T; Balsamelli J; Fanton d'Andon M; Fan Y; Ple C; Werts C; Boneca IG; Wallaert B; Chamaillard M; Tsicopoulos A
    Am J Respir Crit Care Med; 2014 Apr; 189(8):899-908. PubMed ID: 24661094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL17 and CCL22 induce CCR4 receptor expression and promote cytokine-induced killer cells migration.
    Dong Y; Gao S; Zhang X; Kou J; Liu J; Ye T; Shen H
    Anticancer Drugs; 2022 Feb; 33(2):149-157. PubMed ID: 34657098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high-throughput chemotaxis detection method for CCR4
    Magnotti EL; Chan LL; Zhu Q; Marasco WA
    J Immunol Methods; 2020 Apr; 479():112747. PubMed ID: 31958449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.